Blockchain Registration Transaction Record

Cybin CEO to Spotlight Psychedelic Therapeutics at 2025 Conference

Cybin Inc. CEO to discuss psychedelic therapeutics at Psychedelic Science 2025, showcasing innovative mental health treatments. Learn more about their groundbreaking research.

Cybin CEO to Spotlight Psychedelic Therapeutics at 2025 Conference

This news is significant as it highlights the growing acceptance and development of psychedelic-based treatments for mental health conditions, which could revolutionize the way these conditions are treated. Cybin's participation in the Psychedelic Science 2025 Conference and its ongoing research into treatments for major depressive disorder and generalized anxiety disorder represent a promising frontier in mental healthcare, offering hope to millions affected by these conditions worldwide.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x584ef6f707c3d43a7ff6625fab8e7f5f676466484ae1eb6260ddaccc7262a7a9
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintdavev9yY-2586ee18fece4686ade46a88e60bfc9c